Medical Research Council

Similar documents
December Eucomed HTA Position Paper UK support from ABHI

The Defence of Basic

Impact Case Study Template. Guidance Document

Impact for Social Sciences and the Handbook for Social Scientists

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

Science and engineering driving the global economy David Delpy, CEO May 2012

Research Excellence Framework

ABHI Response to the Kennedy short study on Valuing Innovation

Strategic Plan Public engagement with research

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

Public engagement, impact, and the 21st Century University: the context. Paul Manners Director, National Coordinating Centre for Public Engagement

What is on the Horizon? 2020

Scottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund

THE IMPACT OF SCIENCE DISCUSSION PAPER

Getting the evidence: Using research in policy making

NHS Next Stage Review: Innovation

COMMISSION STAFF WORKING PAPER EXECUTIVE SUMMARY OF THE IMPACT ASSESSMENT. Accompanying the

Review of the University vision, ambition and strategy January 2016 Sir David Bell KCB, Vice-Chancellor

Research and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research

Priorities for medical research in the UK

Local Growth and the changing innovation landscape

RESEARCH.DISCOVER.INNOVATE. RESEARCH.DISCOVER.INNOVATE. RESEARCH.DISCOVER.INNOVATE.

Centre for Healthcare Technologies

What s going on at the MRC

Expectations around Impact in Horizon 2020

Policy Partnership on Science, Technology and Innovation Strategic Plan ( ) (Endorsed)

Whole of Society Conflict Prevention and Peacebuilding

executives are often viewed to better understand the merits of scientific over commercial solutions.

The Policy Content and Process in an SDG Context: Objectives, Instruments, Capabilities and Stages

Science Integration Fellowship: California Ocean Science Trust & Humboldt State University

General Assembly. United Nations A/63/411. Information and communication technologies for development. I. Introduction. Report of the Second Committee

Translational scientist competency profile

Second Annual Forum on Science, Technology and Innovation for the Sustainable Development Goals

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective

Please send your responses by to: This consultation closes on Friday, 8 April 2016.

GLOBAL EDUCATION DIALOGUES STIMULUS PAPER

Catapult Network Summary

Societal engagement in Horizon 2020

Sustainable Society Network+ Research Call

Innovation in HTA: What is the additional value?

Marie Curie Actions - 15 years of boosting research careers in Europe

Roadmap for European Universities in Energy December 2016

Projects will start no later than February 2013 and run for 6 months.

Constants and Variables in 30 Years of Science and Technology Policy. Luke Georghiou University of Manchester Presentation for NISTEP 30 Symposium

Before I talk through the strategy itself, I want to tell you more about why

2. Evidence themes and their importance along the development path

Technology Platforms: champions to leverage knowledge for growth

Strengthening the Contribution of English Higher Education Institutions to the Innovation System: Knowledge Exchange and HEIF Funding

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Research Development Request - Profile Template. European Commission

Infrastructure, International

EU Research Integrity Initiative

Lord Drayson of Kensington Minister of State for Science and Innovation Department for Innovation, Universities and Skills

The petroleum industry, internationalisation, 11 and technology development. Industry development and internationalisation

Building global engagement in research Sources of funding for enabling international research collaborations

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

European Charter for Access to Research Infrastructures - DRAFT

EPSRC Funding for Engineering

COLLIDE International Award 2018

PIONEERING A DIGITAL FUTURE Research Councils UK Digital Economy Programme DIGITAL ECONOMY

SECTION OF DEPUTY PRIME MINISTER FOR THE SCIENCE, RESEARCH AND INNOVATION. Government of the Czech Republic

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

9 October Opportunities to Promote Data Sharing UCL and the YODA Project. Emma White. Associate Director

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif

ASEAN: A Growth Centre in the Global Economy

Industrial Strategy Challenge Fund. Dr Jon Wood Manager for

How to Evidence and Record Policy Impact

Research Infrastructure Programme

The Method Toolbox of TA. PACITA Summer School 2014 Marie Louise Jørgensen, The Danish Board of Technology Foundation

Committee on Development and Intellectual Property (CDIP)

GENEVA COMMITTEE ON DEVELOPMENT AND INTELLECTUAL PROPERTY (CDIP) Fifth Session Geneva, April 26 to 30, 2010

13 December A NERA Briefing: Expert Workshop on HTA Workshop Sponsored by Pfizer

THE UNIVERSITY OF MANCHESTER PARTICULARS OF APPOINTMENT FACULTY OF HUMANITIES SCHOOL OF SOCIAL SCIENCES SOCIAL ANTHROPOLOGY DALTON RESEARCH ASSOCIATE

The Center for Emerging and Innovative Sciences University of Rochester September 5, 2013

g~:~: P Holdren ~\k, rjj/1~

Education and Culture

A Science & Innovation Audit for the West Midlands

Centralised Impact Assessment of EU Co-Funded Projects. Angus Hunter PLATFORM Annual Event 2016 Ljubljana, 6 October 2016

The New Delhi Communiqué

Innovative Approaches in Collaborative Planning

SECOND GLOBAL SYMPOSIUM ON HEALTH SYSTEMS RESEARCH SCIENCE TO ACCELERATE UNIVERSAL HEALTH COVERAGE

FINLAND. The use of different types of policy instruments; and/or Attention or support given to particular S&T policy areas.

Working together to deliver on Europe 2020

COST FP9 Position Paper

WIPO Development Agenda

Helping your business grow in the UK health system

Mainstreaming PE in Horizon 2020: perspectives and ambitions

Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value

RESEARCH AND INNOVATION STRATEGY. ANZPAA National Institute of Forensic Science

From FP7 towards Horizon 2020 Workshop on " Research performance measurement and the impact of innovation in Europe" IPERF, Luxembourg, 31/10/2013

The 45 Adopted Recommendations under the WIPO Development Agenda

National Workshop on Responsible Research & Innovation in Australia 7 February 2017, Canberra

Health Policy Conference Centre for Health Services

VSNU December Broadening EU s horizons. Position paper FP9

Guidelines 12 on Sustainability Science in Research and Education 3

Canadian Health Food Association. Pre-budget consultations in advance of the 2018 budget

GOVERNMENT RESOLUTION ON THE OBJECTIVES OF THE NATIONAL INFORMATION SOCIETY POLICY FOR

EU RESEARCH Nanotechnologies and Advanced Materials and beyond. Safe Nanotechnology. Dr. Georgios Katalagarianakis European Commission

Transcription:

Research Evaluation in the UK Ian Viney Medical Research Council

Approaches used to understand and influence research impact 1. Collect comprehensive evidence of the progress, productivity and quality of research output 2. Support research on the science of science 3. Encourage researchers to think about, and act to maximise, their pathways to impact 4. Introduce the assessment of impact into the allocation of funds for UK Universities

Funding flows in UK science Taken from The Scientific Century (Royal Society 2010)

1. Gathering evidence of progress/productivity p (MRC e-val) MRC e-val is an online system to gather evidenced outputs/outcomes/impacts /i arising i from MRC research better communicate the benefits of MRC funding support strategy development/evaluation understand the linkages between output and the economic, societal and academic impact of MRC research set case studies in context of the productivity and quality of all MRC output Codify outputs other than papers and patents (e.g. influence on policy, development of products) Prospectively track progress over time

2 years of data gathering 3,000 researchers 70,000 reports of output Outputs since 2006 Feedback on 2bn MRC spend (92%)

MRC e-val 2010 results Details of 5,000 active collaborations involving 6,000 partners (20% of MRC researchers have had a productive interaction with the private sector since 2006) 66 spin out companies with an evidenced link to MRC research (35 formed since 2006) Over 130 citations in policy documents, including 30 citations in NICE guidelines since 2006 360 new products and interventions in development, around 40 launched onto the market since 2006, including 10 new drugs 300m of inward investment to UK research and development from overseas and private sector research funding between 2006 and 2010 (around 30% of leveraged funding) 200 published patents since 2006 (roughly 30% are licensed) 37,500 publications reported (30,000 papers between 2006-2010)

2. Medical Research: What s it worth? (2008) Consistent time series for medical research funding in CVD and MH from 1975-1992 Clear conceptual framework relating to GDP gain from spillovers Estimation from literature of the magnitude of this GDP return Development and application to CVD and MH, of a bottom-up approach to estimate health gain in terms of QALYs Analysis of UK guidelines (5 CVD and 12 MH) to provide indicators of lags and proportion of benefits attributable to UK Suggestions for developing research agenda Strong quantitative argument for investment Strong quantitative argument for investment in medical research

3. RCUK Pathways to Impact 7 UK Research Councils together allocate 3bn each year to research Key principle - Excellent research leads to economic, academic and societal impact UK Research Councils seek to: Foster global economic performance, and specifically the economic competitiveness of the UK Enhance the science base, providing skilled people, technologies/methodologies and new knowledge Increase the effectiveness of public services and policy Enhance quality of life, health and creative output RCUK is keen to assess efforts to maximise impact, beginning with the peer review process Pathways to Impact Applications should explore ways to enhance potential impact not predict impact http://impacts.rcuk.ac.uk/default.htm

4. HEFCE Research Excellence Framework (REF) Higher Education Funding Councils in the UK allocate around 2 billion of support for research to Universities each year The REF will assess research outputs, impacts and the research environment at each UK University Assessment is at the level of substantive bodies of research in coherent discipline groups (Units of Assessment UOA ) there are roughly 30 UOA HEFCE ran an impact assessment pilot involving 29 Universities (each submitting case studies for 2 UOAs) across 5 UOAs in total (results published in 2010) Impacts had to be evidenced as occurring in the assessment period 2003-2008, resulting from excellent research supported from 1993 (up to 15years ago) Impact assessment using expert panels was considered workable across all Impact assessment using expert panels was considered workable across all disciplines, and will contribute 20% of the overall REF assessment

Benefits of research Clinical Medicine Impacts on patient outcomes, health policy and practice, medical technology and the pharmaceutical industry Physics Impacts on high-tech products and services, public engagement with science and defence and energy policy Earth systems & environmental sciences Impacts on environmental policy, conservation, managing the environmental, utilities, risks and hazards, exploration of resources, public health Social work & social policy Impacts on social policy, public services, third sector, practitioners and public debate English language & literature Impacts p on creative industries, cultural enrichment, civil society, English as a global product, policy development

Changes in the UK Developing The Impact Agenda In the 2010 Comprehensive Spending Review, HM Treasury stated that MRC s budget would be protected in real terms (providing for an inflationary increase), and the science budget overall given flat cash. The Science Minister noted evidence is now coming in of economic returns to science. The empirical research has been very helpful. Other research funding agencies in the UK are implementing i processes to gather output data similar to MRC e-val, including other Research Councils and medical research charities. Discussions are underway to harmonise and rationalise data collection approaches across multiple funding agencies, and provide more of a UK wide view of research output The importance of capturing and describing, understanding, and assessing impact, with a view to maximising it, is now more accepted in the UK Plans are underway to increase the investment in science of science work Government focus is on economic growth

What has worked? What is transferable? Very early stages of developing our evaluative capability, but some success in demonstrating return on investment Funding agency perspective, follow projects and programmes, aggregate results Survey researchers for evidenced outputs that cannot be gathered from other sources, replace end of grant reports with an ongoing dialogue Too early to tell whether pathways to impact has been successful, but this has begun the debate about what might lead to impact and has gained acceptance REF will be used to allocate funds to Universities in 2014, support has been won across disciplines for impact assessment to play a significant part